<?xml version="1.0" encoding="UTF-8"?>
<p>Due to the emergency situation, since it would be time- and resource-consuming to develop ad hoc specific therapeutics, scientists are exploring three major approaches: (i) the feasibility of utilizing already existing broad-spectrum anti-viral drugs, (ii) the possibility of modifying/adapting them, taking into account the biochemical and biophysical features of the novel virus, and (iii) exploiting available pharmaceutics (either belonging to Western or Chinese traditional medicine) for other therapeutic purposes (drug repositioning or repurposing) [
 <xref rid="B2-ijerph-17-03176" ref-type="bibr">2</xref>]. 
</p>
